Companies immune from rate rises: Sonic Healthcare, Cochlear, Transurban
Fund Manager Chris Pedersen discusses the RBA's rate hike, inflation, banks, dividend growth stocks, Sonic Healthcare, Transurban Group and Cochlear.
Watch Now
Sonic Healthcare is a global healthcare company with a reputation for excellence in laboratory medicine/pathology, radiology/diagnostic imaging and primary care medical services.
Headquartered in Sydney, Australia, Sonic has grown to become one of the world’s leading healthcare providers with operations in Australia, the USA, Germany, Switzerland, the United Kingdom, Belgium, Ireland and New Zealand.
Sonic’s unwavering commitment to a culture of Medical Leadership has been instrumental in our ongoing operational and financial success. This management philosophy, which values the leadership contribution of medical, scientific and technical specialists, embodies a commitment to honouring the doctor–patient relationship, and allows Sonic to consistently deliver the highest levels of service quality, professionalism and best-practice medical care.
Fund Manager Chris Pedersen discusses the RBA's rate hike, inflation, banks, dividend growth stocks, Sonic Healthcare, Transurban Group and Cochlear.
Watch Now
Shares in global pathology and radiology group Sonic Healthcare (ASX:SHL) fell more than 11% after the company turned an earlier earnings nudge into a full-blown downgrade.
Read More
Sonic Healthcare (ASX:SHL) has increased its dividend despite significant declines in earnings during the first half of December, triggered by the easing of the Covid pandemic.
Read More
Sonic Healthcare has announced its acquisition of Swiss laboratory network Synlab Suisse for CHF100m ($250.9m).
Read More
In times like this, with heightened volatility and uncertainty, IML's Bruce Du suggests three quality companies better placed to ride out the rough weather.
Read More
The local earnings season rolled along Wednesday in a slightly happier environment for all concerned - here's what Worley Group, Sonic Healthcare and APA Group had to say.
Read More
The broker reduces the target to $39 from $40 and retains an Outperform rating.
Read More
Morgans lowers its rating to Hold from Add and slashes its target price to $39.93 from $50.72.
Read More
Pandemic-related damage popped up in a couple of interims from retail groups on Monday, while Sonic Healthcare’s good run may just be petering out and A2 Milk’s luck about to turn.
Read More
The target price for Sonic Healthcare rises to $42.40 from $42.25 and the Neutral rating is maintained.
Read More
Plenty of news from the AGMs of steelmaker BlueScope and pathology giant Sonic Healthcare, with guidance and trading updates provided at each. Here are the salient points.
Read More